Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  Breaking News: FDA Approves Triumeq, New Once-Daily Combination Pill
   
Ask the Experts About

Choosing Your MedsChoosing Your Meds
           
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  
  • Email Email
  • Glossary Glossary


Epzicom
Jun 16, 2005

i am on ziagen and epivir the past year, i wonder why my dr will not switch me to Epzicom. Any risks in taking this combination in a single dose. My CD 4 is 180 and VL undetected for a year and a half. CD4 is slow but sure and i am optimistic. it has tripled in a year and a half. should i pursue Epzicom ? it would save me $$. thanks

Response from Dr. Young

Thanks for your post.

Epzicom is the same as full dose Ziagen (abacavir) and Epivir (3TC). The advantages are 1 less pill, 1 less copayment and if you're not already doing it, Epzicom can be taken once a day.

Since it's the same as the two medications you're currently taking, I can see no reason why you couldn't switch to the newer medication. BY



Previous
Drugs that cross the blood-brain barrier
Next
reyataz and food

  
  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS


 
Advertisement



Q&A TERMS OF USE

This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint

Advertisement